InvestSMART

Lumos Diagnostics Holdings Limited (ASX: LDX) - Announcements

Current share price for LDX : $0.110 0.005 (4.35%)+

ASX company news and announcements for Lumos Diagnostics Holdings Limited (LDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Lumos Diagnostics Holdings Limited (LDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Lumos Diagnostics Holdings Limited (LDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Lumos Diagnostics Holdings Limited (LDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$104 Lumos Signs Major Development and IP Agreements with Hologic 11 Jan 2024 9:43AM $0.082 $0.110 risen by 34.15%
$104 Change in substantial holding 7 Dec 2023 2:05PM $0.060 $0.110 risen by 83.33%
$104 Commercial Operations Update Webinar Presentation 6 Dec 2023 8:48AM $0.073 $0.110 risen by 50.68%
$104 Commercial Update Webinar US Product Launch Activities 4 Dec 2023 1:35PM $0.069 $0.110 risen by 59.42%
$104 Lumos Diagnostics FY2023 Full Year Results Webinar 4 Dec 2023 8:35AM $0.062 $0.110 risen by 77.42%
$104 Becoming a substantial holder from RYD 14 Nov 2023 2:13PM $0.071 $0.110 risen by 54.93%
$104 Change in substantial holding 3 Nov 2023 3:55PM $0.080 $0.110 risen by 37.50%
$104 Section 708A Cleansing Statement 3 Nov 2023 11:35AM $0.078 $0.110 risen by 41.03%
$104 Application for quotation of securities - LDX 3 Nov 2023 11:31AM $0.078 $0.110 risen by 41.03%
$104 Update - Proposed issue of securities - LDX 2 Nov 2023 5:11PM $0.074 $0.110 risen by 48.65%
$104 Results of Annual General Meeting 2 Nov 2023 1:52PM $0.075 $0.110 risen by 46.67%
$104 Correction to 2023 AGM Presentation 2 Nov 2023 10:51AM $0.075 $0.110 risen by 46.67%
$104 2023 AGM Presentation 2 Nov 2023 8:50AM $0.074 $0.110 risen by 48.65%
$104 AGM Chair Address 2 Nov 2023 8:46AM $0.074 $0.110 risen by 48.65%
$104 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2023 8:43AM $0.074 $0.110 risen by 48.65%
$104 Proposed issue of securities - LDX 30 Oct 2023 9:43AM $0.078 $0.110 risen by 41.03%
$104 LDX Raises A$2.65 Million in Successful Placement 30 Oct 2023 9:37AM $0.078 $0.110 risen by 41.03%
$104 Change of Director's Interest Notice - DW 24 Oct 2023 9:28AM $0.082 $0.110 risen by 34.15%
$104 Notification of cessation of securities - LDX 13 Oct 2023 1:46PM $0.103 $0.110 risen by 7.32%
$104 Notice of Annual General Meeting and Proxy Form 2 Oct 2023 1:02PM $0.100 $0.110 risen by 10%
$104 Consultancy Arrangement 28 Sep 2023 9:26AM $0.105 $0.110 risen by 4.76%
$104 Cancellation of Investor Roadshow Webinar 18 Sep 2023 8:25AM $0.110 $0.110 fallen by 0%
$104 Lumos Diagnostics Investor Roadshow Webinar 15 Sep 2023 10:37AM $0.110 $0.110 fallen by 0%
$104 FDA Grants EUA for ViraDx 11 Sep 2023 9:33AM $0.095 $0.110 risen by 15.79%
$104 Ceasing to be a substantial holder 11 Sep 2023 8:14AM $0.095 $0.110 risen by 15.79%

251 - 275 of 544 results

Page 11 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.